test

Frank C Detterbeck MD, FACS, FCCP

Professor of Surgery (Section of Thoracic Surgery); Chief, Thoracic Surgery; Surgical Director, Thoracic Oncology; Clinical Program Leader, Thoracic Oncology Program, Smilow Cancer Hospital

Research Interests

Cancer biology; Cancer imaging techniques; Prognostic markers of cancers; Multimodality (multiple therapies for) treatment of cancer; Evidence-based medicine


Selected Publications

  • Anagnostou VK, Bepler G, Syrigos KN, Tanoue LT, Gettinger S, Homer RJ, Boffa D, Detterbeck FC, Rimm DL. High expression of mTOR (mammalian target of rapamycin) is associated with better outcome in non-small cell lung cancer. J Clin Oncol 2009;15:4157-64
  • Detterbeck FC., Boffa D, Tanoue LT. The New Lung Cancer Staging System. Chest 2009;136:260-71
  • Detterbeck FC, Socinski MA, Gralla RJ, Edelman MJ, Jahan TM, Loesch DM, Limentani SA, Govindan R, Ye Z, Monberg M, Obasaju CK. Neoadjuvant Chemotherapy with Gemcitabine-Containing Regimens in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC). J Thor Oncol 2008;3:37-45
  • Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. Invasive Staging of Lung Cancer: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) (Invited Review) Chest. 2007 Sep;132(3 Suppl):202S-220S.
  • Parsons AM, Ennis EK, Yankaskas BC, Parker LA, Hyslop WB, Detterbeck FC. Helical CT Inaccuracy in the Detection of Pulmonary Metastases: Can it be Improved? Ann Thor Surg, 2007; 84:1830-7
  • Detterbeck FC: The clinical value of the WHO classification system of thymoma. Ann Thor Surg 2006;81(6):2328-34

Edit Profile